WithdrawnNCT05932979
Effect of the Administration of L-arginine vs. Placebo in Patients Diagnosed With Presbyvestibulopathy.
PHASE2 · 0 planned enrolment
- Countries listed
- 1
- Registry update
- February 15, 2024
immortal.lifeTrial registrations containing the exact intervention label L-arginine.
No aliases or equivalent products have been inferred.
This is a registry availability fact, not a safety result, comparison, or conclusion.
Understand the safety boundary →PHASE2 · 0 planned enrolment
Phase not reported · 120 planned enrolment